Xenon Pharmaceuticals Inc. (XENE) › Total AssetsXenon Pharmaceuticals Inc. (XENE) — Total AssetsAnnual figures by fiscal year, from SEC filings.2013: $54.49M2014: $87.42M2015: $63.95M2016: $67.49M2017: $46.12M2018: $122.43M2019: $147.70M2020: $189.19M2021: $572.01M2022: $754.15M2023: $964.80M2024: $798.14M2025: $633.16M$633.16M2013Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$633.16M-20.7%2024$798.14M-17.3%2023$964.80M+27.9%2022$754.15M+31.8%2021$572.01M+202.4%2020$189.19M+28.1%2019$147.70M+20.6%2018$122.43M+165.4%2017$46.12M-31.7%2016$67.49M+5.5%2015$63.95M-26.8%2014$87.42M+60.4%2013$54.49M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share